Madonna Rehabilitation Hospitals - Omaha Campus, 17500 Burke Street, OMAHA, NE, 68118, USA
Latest report:
Covid-19 OSHA Complaint
3 years ago
Staff and Patients being repeatedly exposed to Covid- 19 from to the facility not providing workers with proper protection with symptomatic patients and not testing symptomatic patients in a timely manner. The facility has had several patients test positive for Covid and the staff caring for the
…
patients testing positive as well. Workers are being required to return to work while experiencing active symptoms of Covid after 10 days have passed from positive test results, saying that after the 10 days they are safe to return and would be an unexcused absence if they do not return to work. Patient families have called and complained that loved ones have been sent home with Covid from the facility. A patient that was requiring high flow oxygen of 6 plus liters was given a chest xray and the radiologist and pulmonologist reported that they were certain that the patient had Covid Pneumonia. The patient was tested for covid, but they did not protect the staff from exposure to the patient. Staff is told an N95 was not needed unless the patient tested positive for Covid and his test was still pending. Staff entering the patient's room were provided with gown, face shield, surgical mask, and gloves. Staff was exposed for over 8 hours to this patient before his his test came back positive for Covid 19. Staff who cared for that patient coming back to work later in the week said they were never contacted by employee health to warn them of possible exposure, so they were unable to take necessary precautions to protect their family. Another patient that tested positive for Covid uses a CPAP at night this is an aerosol generating procedure. Testing was put off on this patient even though they were symptomatic based on the fact that they had been tested previously, despite repetitive requests for testing. Staff members were entering this room without N95s and then entering other patient rooms. Staff members working on that unit tested positive and many of the patients on that unit tested positive as well.
Alleged Hazards: 1, Employees Exposed: 25
Source: Osha.gov | Receipt Date: 2020-12-16
Alleged Hazards: 1, Employees Exposed: 25
Source: Osha.gov | Receipt Date: 2020-12-16
282
Recent Interesting Reports
Keep sending product. Want to cancel., Wichita, KS, USA
4 days ago •reported by user-xytn2795
Sent a second order and charged my credit card for second order when web site said one shipment.
222
AuroMedics Pharma Methocarbamol Injection - recalled due to Particulate Matter presence, USA
3 weeks ago •source www.fda.gov
Recall notice
Eugia US LLC (f/k/a AuroMedics Pharma LLC) has initiated a voluntary recall of lot number 3MC23011 of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) - 10mL Vial to the consumer level due to a customer product complaint for the presence of white particles floating
…
inside of the vial.
Administration of an injectable product that contains particulate matter may result in local irritation or swelling. If the particulate matter reaches the blood vessels or is injected intravascularly it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Eugia US LLC has not received any reports of adverse events related to this recall.
Methocarbamol injection USP 1000 mg/10 mL (100mg/mL), is used as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is packaged in 10 mL and packed as 25 (vials) X 04 (Printed E-Flute cartons) X 01 (Shipper) with NDC code as 55150-223-10. Eugia US LLC shipped the entire lot to wholesalers nationwide from Jan 12, 2024, through Jan 16, 2024.
The product can be identified by product name on carton and vial label and with lot number 3MC23011 and Exp. Date: Nov 2026 (NDC 55150-223-10) (See enclosed vial label). The product label is as shown in the image below.
Eugia US LLC (f/k/a AuroMedics Pharma LLC) is notifying its distributors by recall letters and is arranging for the return/replacement of all recalled products. Wholesalers, hospitals, pharmacies, institutions, and doctors with an existing inventory of the recalled product lot should discontinue use, stop distribution and quarantine the product immediately. If you have further distributed the recalled product lot, notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
If you are experiencing any harm after using this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.
Company name: Eugia US LLC
Brand name: Eugia US LLC
Product recalled: Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial)
Reason of the recall: Device & Drug Safety – Presence of Particulate Matter
FDA Recall date: March 28, 2024
Source: www.fda.gov
Administration of an injectable product that contains particulate matter may result in local irritation or swelling. If the particulate matter reaches the blood vessels or is injected intravascularly it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Eugia US LLC has not received any reports of adverse events related to this recall.
Methocarbamol injection USP 1000 mg/10 mL (100mg/mL), is used as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is packaged in 10 mL and packed as 25 (vials) X 04 (Printed E-Flute cartons) X 01 (Shipper) with NDC code as 55150-223-10. Eugia US LLC shipped the entire lot to wholesalers nationwide from Jan 12, 2024, through Jan 16, 2024.
The product can be identified by product name on carton and vial label and with lot number 3MC23011 and Exp. Date: Nov 2026 (NDC 55150-223-10) (See enclosed vial label). The product label is as shown in the image below.
Eugia US LLC (f/k/a AuroMedics Pharma LLC) is notifying its distributors by recall letters and is arranging for the return/replacement of all recalled products. Wholesalers, hospitals, pharmacies, institutions, and doctors with an existing inventory of the recalled product lot should discontinue use, stop distribution and quarantine the product immediately. If you have further distributed the recalled product lot, notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
If you are experiencing any harm after using this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.
Company name: Eugia US LLC
Brand name: Eugia US LLC
Product recalled: Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial)
Reason of the recall: Device & Drug Safety – Presence of Particulate Matter
FDA Recall date: March 28, 2024
Source: www.fda.gov
304
Amneal Vancomycin Hydrochloride for Oral Solution - recalled due to super poteny risk, USA
3 weeks ago •source www.fda.gov
Recall notice
Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can
…
result in an over-potent dosing regimen. The affected Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL lots were distributed Nationwide in the USA directly to Wholesalers and Distributors. The Lots were distributed between 11/09/2023 and 2/20/2024. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall.
Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.
The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.
The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.
Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024
Source: www.fda.gov
Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.
The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.
The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.
Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.
Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024
Source: www.fda.gov
303
Yealdeals is a fake best buy, Mountain Home, Arkansas, USA
4 days ago •reported by user-tpkqm326
I ordered a mattress from what I thought was Best Buy come to find out it is really a fake business calledeald that takes your money and there's no way to call them.
15
Shipment, 192-01 Northern Blvd, Flushing, NY, USA
2 weeks ago •reported by user-jckz3224
I received keto gummies that I did not order.
Please cancel all shipments immediately.
Please cancel all shipments immediately.
Scam, Bucharest, Romania
3 weeks ago •reported by user-gzzr8299
This is the boss of this scam, report him to the police!
51
I got a dress I don’t order, El Paso, TX, USA
4 days ago •reported by user-vhxdb428
I received a something the looked like a dress it is horrible, I don’t even like or how much you charge for it.
280
Scam Package from Heather Motty, 2207 Summit Ave, Union City, NJ, USA
3 weeks ago •reported by user-wfxt7548
Ordered Bras, no return info. Need to be returned, too small. Have no idea who to return the items to.
2.9K
Received product I did not order, Kanosh, UT, USA
1 week ago •reported by user-vmrj9634
Today I received a package that I did NOT place. It was for OzemPill. We know we did not place the order. We document all orders we make.. The package did not have a receipt with it, so there is no record of the alleged date when
…
the order was placed and sent. There is no record of price or even how it was charged.
Any help as to how and why this happened would be helpful and also how to return
Tamara K.
Any help as to how and why this happened would be helpful and also how to return
Tamara K.
Unordered Package from Heathers Motty, 2207 Summit Avenue, Union City, NJ, USA
3 weeks ago •reported by user-chvb6381
I received a package from Heather's Motty from Heathers Motty 2207 Summit Avenue, Union City, NJ. The return address is associated with YUANHENG AAA, LLC which appears to be a Hong Kong based trading and fulfilment company. The company also has an affiliate in Flushing, NY I
…
have ordered products from China based companies, but not recently, and did not order these items.
2.9K
Report by
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Last 30 days